Lisata Therapeutics, Inc. (LSTA)
5.00
-0.02
(-0.40%)
USD |
NASDAQ |
Apr 06, 16:00
4.99
-0.01
(-0.20%)
After-Hours: 20:00
Lisata Therapeutics SG&A Expense (TTM) : 10.43M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Penumbra, Inc. | 663.42M |
| Protalix Biotherapeutics, Inc. | 11.68M |
| PAVmed, Inc. | 17.17M |
| Agenus, Inc. | 54.39M |
| Curis, Inc. | 14.05M |